All Insights
Showing 145 - 156 of 325
Life Sciences and Healthcare
The UK Patents Court puts an arrow through Teva's application for declaratory relief
Court of Appeal makes clear the limits on obtaining Arrow declaratory relief for deployment in other jurisdictions
Intellectual property
Could international and European legal obstacles jeopardise the German government's legislative plan to legalise cannabis?
German government publishes paper with legislative proposals, but the impact of international and European law on its plan is still
Life Sciences and Healthcare
Regulatory Horizons Council makes recommendations to UK government for the regulation of AI as a medical device
'Urgent need to get the regulation right' says RHC report which recommends an increase in regulatory capacity and capability to
Regulatory Outlook
Products | UK Regulatory Outlook November 2022
Government further delays use of UK product safety marking | UK-wide packaging regulations expected to enter into force in late
Intellectual property
Remanufacturing: How to define it and what its legal challenges are
Remanufacturing – the reprocessing of products – has long been considered a niche topic. This is currently changing. More and
Life Sciences and Healthcare
Commercialising health data: five takeaways from the ICO's Easylife decision
What actions should businesses consider when looking to reuse customer health data?
Life Sciences and Healthcare
EU General Court says risk of similarity between cosmetics and pharmaceuticals in trade mark cases
A blurred line between goods means skincare products may be considered similar across classes 3 and 5
Regulatory and compliance
New Belgian medical devices and in vitro diagnostics legislation comes into force
The transposition of EU medtech regulations is progressing in Belgium – with repercussions for all medtech businesses active there.
Life Sciences and Healthcare
UK lays out roadmap for regulation of software and AI as medical devices
What 'deliverables' does the MHRA want from its roadmap and what can be expected from its work packages?
Life Sciences and Healthcare
MHRA moves to assuage medical device manufacturers over UK's post-Brexit plans
Businesses will have more time to prepare for the new UKCA marking regime and comment on draft medical device regulations
Intellectual property
Implausible declarations?
What a recent English Patents Court judgment suggests for the future of litigation
Life Sciences and Healthcare
Payback for medical devices: is litigation on the horizon in Italy?
Doubts linger about the system's legitimacy, retroactivity and application, particularly around calculation errors Seven years since the entry into force
